Date: March 28, 2024
Time: 12:00 PM (PST), 3:00 PM (EST), 8:00 PM (CET)
Gastrointestinal infections challenge the healthcare system, creating a major burden for the hospital, both operationally and financially. Traditional diagnostic methods such as culture, microscopy and immunoassays come with limitations that potentially impact laboratory workflow, budget, clinical decision-making and patient outcomes.
In this webinar, you will hear from three respected key opinion leaders on how transitioning from traditional culture to molecular methods has created positive impact on their laboratory workflow and patients.
Furthermore, you will hear first-hand experience how BD MAXTM System and its Enteric assay panels helped create these positive impacts.
Learning Objectives
- Review impact of targeted BD MAX™ Enteric Panels on laboratories, in terms of turnaround time, workflow efficiency, cost benefit, reduced hazardous waste, and impact on lab staff morale compared to traditional methods.
- Take a closer look at recommended IDSA guidelines for GI pathogens and algorithms put in place at institutions for diagnostic stewardship purposes.
- Hear about a few patient cases and outcomes associated with this molecular testing method.
Webinars will be available for unlimited on-demand viewing after live event.